Physician profile
Tracy A Jansen
NPI 1922031210
$4,607.86
in general payments reported to CMS, 2019-2025
37 companies · $1,114 in 2025
The $1,114 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $747 · 2020: $147 · 2021: $337 · 2022: $718 · 2023: $801 · 2024: $745 · 2025: $1,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,659.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $530.29 | 2024-2025 | Dexcom G6 Transmitter, Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Merck Sharp & Dohme LLC | $483.01 | 2019-2024 | Verquvo, Belsomra, Capvaxive |
| Pfizer INC. | $426.46 | 2019-2025 | |
| Abbvie INC. | $327.96 | 2021-2025 | |
| Novo Nordisk INC | $315.27 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals Lp | $257.04 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $221.17 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Glaxosmithkline, LLC. | $205.42 | 2019-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Astellas Pharma US INC | $190.62 | 2024-2025 | Veozah |
| Amgen INC. | $190.54 | 2019-2025 | Krystexxa, Otezla, Repatha |
| Abbott Laboratories | $163.82 | 2022-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.64 | 2019-2024 | Jardiance |
| Lundbeck LLC | $127.59 | 2022-2025 | Vyepti, Rexulti |
| Janssen Pharmaceuticals, INC | $112.39 | 2020-2024 | Xarelto |
| Allergan, INC. | $90.07 | 2019-2020 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Jansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.